NYSE:TDOCTeladoc Health Stock Price, Forecast & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 66.7% and is now trading at $228.98. View which stocks have been most impacted by Coronavirus.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

Teladoc Health Inc (NYSE:TDOC) posted its quarterly earnings data on Wednesday, April, 29th. The health services provider reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.05. The health services provider earned $180.80 million during the quarter, compared to analyst estimates of $180.64 million. Teladoc Health had a negative return on equity of 10.60% and a negative net margin of 16.24%. The company's revenue for the quarter was up 40.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.43) earnings per share. View Teladoc Health's earnings history.

Teladoc Health updated its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided earnings per share (EPS) guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

25 brokers have issued 1-year price targets for Teladoc Health's stock. Their forecasts range from $80.00 to $250.00. On average, they expect Teladoc Health's stock price to reach $166.13 in the next year. This suggests that the stock has a possible downside of 27.4%. View analysts' price targets for Teladoc Health.

Media coverage about TDOC stock has trended somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Teladoc Health earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Teladoc Health.

Some companies that are related to Teladoc Health include Intuitive Surgical (ISRG), Bayer (BAYRY), Stryker (SYK), Zoetis (ZTS), Anthem (ANTM), Bayer (BAYN), Takeda Pharmaceutical (TAK), Illumina (ILMN), Humana (HUM), Boston Scientific (BSX), Biogen (BIIB), Baxter International (BAX), LONZA GRP AG/ADR (LZAGY), Edwards Lifesciences (EW) and Siemens Healthineers (SHL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (0.84%), Envestnet Asset Management Inc. (0.13%), Spence Asset Management (0.05%), Carnegie Capital Asset Management LLC (0.04%), Legacy Capital Partners Inc. (0.01%) and DNB Asset Management AS (0.01%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health.

TDOC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Spence Asset Management, Gradient Investments LLC, Legacy Capital Partners Inc., Carnegie Capital Asset Management LLC, and Arden Trust Co. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health.

TDOC stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Envestnet Asset Management Inc., IBM Retirement Fund, and Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for Teladoc Health.

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $228.98.

Teladoc Health has a market capitalization of $17.05 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

The official website for Teladoc Health is www.teladoc.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]